Meeting Report
The Next Wave of Novel Agents in Aggressive B-Cell Lymphoma: Highlights From SOHO 2021
Kelly Valla, PharmD, BCOP
J Adv Pract Oncol 2022;13(suppl 1):34–36 |
https://doi.org/10.6004/jadpro.2022.13.1.17 |
© 2022 Harborside™
ABSTRACT
Kelly Valla, PharmD, BCOP, of Winship Cancer Institute of Emory University, describes the clinical implications of novel agents for aggressive B-cell lymphoma, which were described at a session presented by Gilles Salles, MD, PhD, of Memorial Sloan Kettering Cancer Center, at the 2021 SOHO Annual Meeting.
For access to the full length article, please
sign in.